March 30, 2023
Comanche Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for CBP-4888, an siRNA Investigational Therapy for the Treatment of Preeclampsia
December 15, 2022
Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer